Table 3. Association of patient and tumour characteristics with urinary cathepsin D by univariate analysis.
Cathepsin D concentration | |||
---|---|---|---|
Status | Median (range) (ng ml−1 μmolCr−1) | P -value (association) | P -value (trend) |
Normal | 133.2 (40.2, 856.5) | 0.052a | |
Benign | 177.6 (73.9, 536.0) | ||
RCC | 178.0 (27.0, 4274.0) | ||
Control | 144.3 (40.2, 856.5) | 0.113b | |
Sex | 0.188 | ||
Male | 145.5 (27.0, 4274.0) | ||
Female | 200.0 (40.2, 1209.0) | ||
Agec | 0.103c | 0.212 | |
Grade | 0.854 | 0.577 | |
1or2 | 195.0 (27.0, 4274.0) | ||
3 | 178.0 (54.0, 3492.0) | ||
4 | 172.0 (41.0, 2180.0) | ||
Sarcomatoid change | 0.032 | ||
No | 171.0 (27.0,1789.0) | ||
Yes | 380.0 (73.0,2180.0) | ||
pT stage | 0.254 | 0.080 | |
1 | 172.0 (27.0, 4274.0) | ||
2 | 175.0 (70.0, 471.0) | ||
3 | 204.5 (48.0, 3492.0) | ||
4 | 836.0 (86.0, 1789.0) | ||
CT T stage | 0.159 | 0.086 | |
1 | 161.0 (27.0, 4274.0) | ||
2 | 182.0 (27.0, 2180.0) | ||
3 | 325.0 (48.0, 912.0) | ||
4 | 139.0 (86.0, 802.0) | ||
N stage | 0.001 | ||
0 | 165.0 (27.0, 4274.0) | ||
1/2 | 362.0 (60.0, 2180.0) | ||
M stage | 0.034 | ||
0 | 169.0 (27.0, 4274.0) | ||
1 | 251.0 (60.0, 1789.0) | ||
Overall stage | 0.216 | 0.043 | |
I | 165.0 (27.0,4274.0) | ||
II | 175.0 (70.0,376.0) | ||
III | 164.5 (48.0,3492.0) | ||
IV | 224.0 (60.0,1789.0) | ||
Symptoms | 0.368 | 0.190 | |
Local | 169.0 (27.0,4274.0) | ||
Asymptomatic | 172.0 (33.0,3492.0) | ||
Systemic | 226.5 (63.0,912.0) | ||
Tumour size c | |||
CT | 0.143c | 0.109 | |
pathology | 0.115c | 0.173 |
Refers to test comparing normal, benign and renal cell carcinoma (RCC) group.
Refers to test comparing control (normal and benign) with RCC group.
Spearman's rank correlation coefficient.
Age, sex and tumour-related factors relate to RCC group only. P-value (association) is result of test comparing distributions in groups under null hypothesis of them being identical and P-value (trend) is the result of a test under the null hypothesis of no trend in naturally ordinal groups.